BSE filing, NSE: JUBLPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Jubilant Pharmova Ltd: key numbers
- Share price
- ₹923.80
- Market cap
- ₹14,714 Cr
- Revenue (annual)
- ₹8,280 Cr
- Net profit (annual)
- ₹398.5 Cr
- P/E (TTM)
- 41.8×Sector 48.7×
- Promoter holding
- 47.68%+0.00% QoQ
- FII holding
- 15.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jubilant Pharmova Ltd
All →Jubilant Pharmova Board Meeting Date
Jubilant Pharmova has scheduled a board meeting for November 13, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The filing is a Regulation 29 advance intimation only.
Jubilant Pharmova Annual General Meeting
Jubilant Pharmova Ltd has issued a Postal Ballot Notice seeking shareholder approval for the private placement issuance of Non-Convertible Debentures.
Jubilant Pharmova Credit Rating
Jubilant Pharmova received a credit rating of IND AA+/Stable from India Ratings and Research for its proposed Non-Convertible Debentures worth ₹1,400 Crore.
- Value
- ₹1,400 Cr
Jubilant Pharmova Other Announcement
Jubilant Pharmova Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Jubilant Pharmova Credit Rating
Jubilant Pharmova received an [ICRA]AA+ (Stable) rating from ICRA for its proposed non-convertible debentures. This confirms the credit assessment for the upcoming debt instrument.
Jubilant Pharmova Debt & Borrowing: ₹800 Cr
Jubilant Pharmova board approved NCD issuance up to ₹800 crore on private placement basis. Postal ballot also sought for NCD authorization up to ₹2,500 crore.
- Value
- ₹800.0 Cr
- Execution
- Upto five years from the Deemed Date of Allotment
Other board meeting date announcements
All →Mahasagar Travels Board Meeting Date
Mahasagar Travels will hold a board meeting on 5 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window opened 1 October 2026.
Sansera Engineering Board Meeting Date
Sansera Engineering will hold a board meeting on November 5, 2026 to approve unaudited results for the quarter ended September 30, 2026. The trading window for designated persons has been closed since October 1, 2026.
Contil India Board Meeting Date
Contil India will hold a board meeting on 6 November 2026 to consider unaudited standalone half-yearly results. Trading window closed 1 October to 14 November 2026.
GSB Finance Board Meeting Date
Coffers Finvest will hold a board meeting on 4 November 2026 to approve September quarter results. Trading window stays closed until 48 hours after results.
Liotech Industries Board Meeting Date
Liotech Industries will hold a board meeting on November 4, 2026 to consider standalone unaudited results for the half year ended September 30, 2026. The trading window closes from October 1 until 48 hours after the results are declared.
Organic Coatings Board Meeting Date
Organic Coatings will hold a board meeting on November 5, 2026 to consider unaudited Q2 and half-year results. The trading window closes from October 1 until 48 hours after the results are made public.